Apple Inc. has been forced to cease the sales of its Series 9 and Ultra 2 watches with oxygen level monitoring function in the United States. This is another legal setback resulting from a patent dispute with Masimo Corp.
The U.S. Court of Appeals for the Federal Circuit denied the extension of the exclusion order on Wednesday, which had imposed a ban on the import of these devices by the U.S. International Trade Commission. The ruling means that the company must discontinue the sale of smartwatches with oxygen level measurement function during the appeal period, which according to Apple, could last a year or longer.
Apple would be obliged to halt the sale of watches equipped with oxygen level monitoring function due to a proven infringement of Masimo Corp.’s patent. This has resulted in the import ban of these devices in the United States.
Although the ban only applies to the U.S. market, it has a significant impact on Apple’s operations. The company is now forced to adjust its sales strategy in order to minimize the losses incurred from the inability to sell smartwatches with oxygen level monitoring function.
This legal decision may also have long-term consequences for Apple. If the court upholds the ban on the importation of watches, the company may lose a valuable market segment, and its competitors may take advantage of this situation to increase their sales.
In light of these challenges, Apple will need to focus on seeking innovative features and services that will attract customers and compensate for the loss of sales of watches with oxygen level monitoring function. This is a challenge that may require the company to change its strategy and approach to the wearable technology market.
FAQ Section:
The source of the article is from the blog be3.sk